Name | Description | URL | Journal | Year | PMID |
---|---|---|---|---|---|
ExomiRHub | ExomiRHub: a comprehensive database platform to integrate, analyze, and visualize the extracellular miRNA transcriptome of human diseases |
http://www.biomedical-web.com/exomirhub/ |
Computational and Structural Biotechnology Journal | 2024 | 39219717 |
ExpOmics | ExpOmics: a comprehensive web platform empowering biologists with robust multi-omics data analysis capabilities | http://www.biomedical-web.com/expomics/ | Bioinformatics | 2024 | 39128019 |
circMine | circMine: a comprehensive database to integrate, analyze and visualize human disease-related circRNA transcriptome |
http://www.biomedical-web.com/circmine/ |
Nucleic Acids Research | 2022 | 34530446 |
COVID19db | COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale |
http://www.biomedical-web.com/covid19db |
Nucleic Acids Research | 2022 | 34554255 |
CanImmunther | CanImmunother:a manually curated database for identification of cancer immunotherapies associating with biomarkers,targets, and clinical effects | http://www.biomedical-web.com/cancerit/ | OncoImmunology | 2021 | 34345532 |
MicroPhenoDB | MicroPhenoDB associates etagenomic data with pathogenic microbes, microbial core genes and human disease phenotypes | http://lilab2.sysu.edu.cn/microphenodb/#/home | Genomics, Proteomics & Bioinformatics | 2020 | 33418085 |
ncRPheno | ncRPheno: a comprehensive database platform for identification and validation of disease related noncoding RNAs | http://lilab2.sysu.edu.cn/ncrpheno | RNA Biology | 2020 | 32122231 |
ncRNAVar | ncRNAVar: A Manually Curated Database for Identification of Noncoding RNA Variants Associated with Human Diseases | http://www.liwzlab.cn/ncrnavar/ | Journal of Molecular Biology | 2021 | 33275967 |
LncDrug | LncDrug: an interactive web platform to discover the role of translatable lncRNA in drug response at whole transcriptome level | http://www.biomedical-web.com/lncdrug | - | 2024 | - |